![Mark Lundie](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Lundie
Direktor/Vorstandsmitglied bei Clinical Trials Ontario
Aktive Positionen von Mark Lundie
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Clinical Trials Ontario
![]() Clinical Trials Ontario Miscellaneous Commercial ServicesCommercial Services Clinical Trials Ontario operates as a research and development company for various diseases. The company was founded in 2012 and is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | - | - |
Unternehmenssekretär | - | - | |
Ontario Genomics Institute (Private Equity)
![]() Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Mark Lundie
Ehemalige bekannte Positionen von Mark Lundie
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Centre For Probe Development & Commercialization
![]() Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | Direktor/Vorstandsmitglied | - | 17.06.2021 |
Vorsitzender | - | - |
Statistik
International
Kanada | 4 |
Operativ
Director/Board Member | 3 |
Corporate Secretary | 1 |
Chairman | 1 |
Sektoral
Commercial Services | 2 |
Health Technology | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Clinical Trials Ontario
![]() Clinical Trials Ontario Miscellaneous Commercial ServicesCommercial Services Clinical Trials Ontario operates as a research and development company for various diseases. The company was founded in 2012 and is headquartered in Toronto, Canada. | Commercial Services |
Centre For Probe Development & Commercialization
![]() Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | Health Technology |
Ontario Genomics Institute (Private Equity)
![]() Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Finance |
- Börse
- Insiders
- Mark Lundie
- Erfahrung